Name / Stock Number: CS2110859

NASC stock number: N2110859

donor stock number: Gde23 E3V #7

other name: ect2-3/ect3-2/ECT3-Venus L1

Resource Type: seed

Availability: available

  • Laura Arribas Hernandez
  • Peter Brodersen

Donation Date: 08/30/2021

Date Released: 09/27/2021


Complementation line. ect2-3/ect3-2 (Gde23) mutant (CS2110129) expressing the ECT3-Venus protein fusion under the control of the corresponding endogenous ECT3 promoter (ECT3p:ECT3-Venus-ECT3t). Gde23 mutant plants were transformed by floral dipping. Kanamycin resistant. Homozygous for the transgene.

Growth Requirement: none

Marker: kanamycin, sulfadiazine

Background: Col (Columbia)

ABRC Comment:

Format Shipped: 100 seeds per vial

Base / Commercial Price: $13 / $104



complementation of the Gde23 mutant (CS2110129) phenotype

Arabidopsis thaliana 3702

Additional Information

DOI PubMed
10.1105/tpc.17.00833 29643069
Transgene Description Promoter Reporter Marker
pAC161 T-DNA sulfadiazine
ECT3p:ECT3-Venus-ECT3t ECT3-Venus protein fusion with the native ECT3 terminator driven by the ECT3 native promoter ECT3p Venus kanamycin

Quality Control Comments

There is no quality control data for this stock.